Management of refractory chylothorax in pulmonary lymphangioleiomyomatosis

Respirology Case Reports

Claire M. Ellender¹  Trevor J. Williams²  Julian Gooi²  Gregory I. Snell² 

[1] ORCID:orcid.org/0000-0002-1727-576X;Department of Allergy, Immunology and Respiratory Medicine and CJOB Cardiothoracic and Transplant Unit, Alfred Hospital, Monash University, Melbourne, Victoria, Australia

关键词: Chylothorax;    lymphangioleiomyomatosis;    pleurectomy;    rapamycin;    sirolimus;   

DOI  :  10.1002/rcr2.105

来源: Wiley

【 摘 要 】

Abstract

This case reports the successful management of chylothorax in a non-transplanted patient with pulmonary lymphangioleiomyomatosis (pLAM). Prolonged initial therapy failed, including total parenteral nutrition, pleural drainage, surgical pleurodesis, and pleurectomy. Commencement of sirolimus 2 mg daily (2 mg alternating days had failed) led to resolution of chylothorax after 20 days. Discontinuation of sirolimus for abdominal surgery led to recurrence of the chylothorax. Reinstitution of sirolimus led to rapid resolution of the effusion, stabilization of lung function, and there has been no recurrence in the ensuing 4 years. We conclude that sirolimus should be considered in the management of pLAM-related chylothorax, perhaps before surgical intervention.

【 授权许可】

CC BY-NC-ND   
© 2015 The Authors. Respirology Case Reports published by John Wiley & Sons Ltd on behalf of The Asian Pacific Society of Respirology.

Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.